Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Receivables (2024 - 2025)

Carlsmed's Receivables history spans 2 years, with the latest figure at $11.4 million for Q4 2025.

  • For Q4 2025, Receivables rose 67.93% year-over-year to $11.4 million; the TTM value through Dec 2025 reached $11.4 million, up 67.93%, while the annual FY2025 figure was $11.4 million, 67.93% up from the prior year.
  • Receivables reached $11.4 million in Q4 2025 per CARL's latest filing, up from $11.3 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $11.4 million in Q4 2025 to a low of $6.8 million in Q4 2024.